When composing new panels we gather information from widely used public-access bioinformatic databases, including Uniprot, Human Protein Atlas, Gene Ontology (GO) and DisGeNET.
A combination of known, as well as exploratory biomarkers are chosen and evaluated for the availability of suitable antibodies, which then need to pass our strict validation tests and requirements. The selection process and the panel composition are developed together with input from experts within each field.